Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors
about
Ninety-Nine Is Not Enough: Molecular Characterization of Inhibitor-Resistant Human Immunodeficiency Virus Type 1 Protease Mutants with Insertions in the Flap RegionHIV-1 drug resistance and resistance testing.Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transductionClinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in NigeriaIncreased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.Genotypic testing for human immunodeficiency virus type 1 drug resistance.HIV-1 antiretroviral resistance: scientific principles and clinical applicationsInsertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitnessInsertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.NucAmino: a nucleotide to amino acid alignment optimized for virus gene sequencesHIV-1 drug resistance mutations: an updated framework for the second decade of HAARTMolecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DNMolecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.Coexistence of HIV-1 variants with dipeptidic insertion in the reverse transcriptase gene.Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.
P2860
Q27650299-0962395E-F17D-40DF-90D4-A9CE86393283Q30245693-E031F145-08E5-479A-B32E-B69935E76B35Q30354965-D6C7C52F-F556-482C-901E-FDCCC5966F1FQ33625367-2C32184B-0523-46CF-A393-BB6F04AFBE02Q33737755-C7C80F44-6A14-42BF-BC46-2BC4072C5EB6Q33906239-5798467E-2F15-4893-9FB3-67EF901902F1Q34280466-4A45F21D-E09D-4AF6-97CC-8C7277FA7776Q34348774-BDEC2E98-2F3D-4687-BF4A-D0E494B4E252Q34430752-218AE54A-D02F-4F29-8889-74653BE4C068Q34489239-53830D4E-399A-400E-8B63-7A4A9D77CFADQ34651403-8C459D8A-5C04-437C-A473-18C0F30FC311Q36175788-0AC39AB9-E597-4795-B004-8AA86EB7CC05Q36294376-FA8537B9-1992-4C8D-90C1-F76C4DC1CE1AQ36900010-79B7EEB5-46DA-494D-A41A-C0B60D7EFD3AQ38343144-34923AF6-5D25-4C40-A3D8-2ABDCA84FCDAQ38344427-C77E4A7C-1FEE-4872-94A8-F14511302FCAQ39732544-29767F81-22C2-48EE-BE90-EEB77770ED80Q40173457-2F1C2DC9-C97B-4CFD-BBBE-35A23B63A7A6Q42248539-E8A35B7F-D34C-4356-B524-598312B84D4DQ42737965-E73767E4-D9D8-4FA1-9635-BA3BC2240BB7Q42770670-492FCE73-DE87-4EB9-83D8-B57CB63C45F3Q44183256-1FB48C03-DB4D-41BD-8B34-14B55423DF28Q46000779-E91A2939-7C4D-4060-8381-24809CDEBDB4Q52319934-4C7CF49B-CEAE-4A65-8C62-CA8AAEA7BD1EQ53911156-09BB0570-4099-43F3-82E4-EB8503EBCCD8
P2860
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@ast
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@en
type
label
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@ast
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@en
prefLabel
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@ast
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@en
P2093
P2860
P1476
Genotypic and phenotypic resis ...... nts treated with RT inhibitors
@en
P2093
A Ruffault
A S Mohammed
ANRS AC11 Resistance study group. French Agence Nationale de Recherches sur le SIDA
B Masquelier
C Buffet-Janvresse
D Descamps
P2860
P304
P356
10.1128/AAC.45.6.1836-1842.2001
P407
P577
2001-06-01T00:00:00Z